Theratechnologies Inc
THTX3.390USD
0.000
종가 11/06, 16:00（ET）시세는 15분 지연됩니다
155.87M시가총액
손실P/E TTM
자세한 내용은 Theratechnologies Inc 회사
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
Theratechnologies Inc 정보
종목 코드 THTX
회사 이름Theratechnologies Inc
상장일Dec 21, 1993
CEOMr. Paul Levesque
직원 수94
유형Ordinary Share
회계 연도 종료Dec 21
주소2015 Peel Street, 11th Floor
도시MONTREAL
증권 거래소NASDAQ Capital Market Consolidated
국가Canada
우편 번호H3A 1T8
전화15143367800
웹사이트https://www.theratech.com/
종목 코드 THTX
상장일Dec 21, 1993
CEOMr. Paul Levesque
Theratechnologies Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
Ms. Dale Maccandlish Weil
Ms. Dale Maccandlish Weil
Independent Director
Independent Director
--
-100.00%
Mr. Andre Dupras
Mr. Andre Dupras
Vice President of Human Resources
Vice President of Human Resources
--
--
Ms. Elina Tea
Ms. Elina Tea
Independent Director
Independent Director
--
--
Mr. Andrew Thomas Molson
Mr. Andrew Thomas Molson
Independent Director
Independent Director
--
-100.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
EGRIFTA
11.13M
62.78%
Trogarzo
6.60M
37.22%
지역별USD
이름
수익
비율
United States
17.73M
100.00%
사업별
지역별
사업별USD
이름
수익
비율
EGRIFTA
11.13M
62.78%
Trogarzo
6.60M
37.22%
주식 보유 통계
마지막 업데이트: Fri, Oct 17
마지막 업데이트: Fri, Oct 17
주주
주주 유형
주주
주주
비율
Future Pak LLC
100.00%
Worth Venture Partners, LLC
1.16%
Trium Capital LLP
0.69%
National Bank of Canada
0.48%
Stonepine Capital Management, LLC
0.41%
주주
주주
비율
Future Pak LLC
100.00%
Worth Venture Partners, LLC
1.16%
Trium Capital LLP
0.69%
National Bank of Canada
0.48%
Stonepine Capital Management, LLC
0.41%
주주 유형
주주
비율
Corporation
100.00%
Investment Advisor/Hedge Fund
2.82%
Investment Advisor
1.66%
Bank and Trust
0.48%
Research Firm
0.32%
Hedge Fund
0.16%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
75
2.49M
5.41%
-18.09M
2025Q2
91
22.32M
48.54%
-1.07M
2025Q1
91
22.45M
48.83%
-1.34M
2024Q4
86
23.57M
51.25%
-895.81K
2024Q3
83
24.25M
52.74%
-40.47K
2024Q2
85
24.07M
52.35%
-127.35K
2024Q1
90
23.97M
52.12%
-218.82K
2023Q4
90
24.01M
52.22%
+1.91M
2023Q3
92
7.44M
30.84%
-1.19M
2023Q2
93
7.55M
31.28%
-1.05M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Worth Venture Partners, LLC
533.40K
1.16%
-43.52K
-7.54%
Jun 30, 2025
National Bank of Canada
222.87K
0.48%
+25.80K
+13.09%
Jun 30, 2025
Stonepine Capital Management, LLC
189.05K
0.41%
+163.23K
+632.05%
Jun 30, 2025
SEB Investment Management AB
132.64K
0.29%
+132.64K
--
Jun 30, 2025
Dimensional Fund Advisors, L.P.
107.48K
0.23%
+77.64K
+260.12%
Jun 30, 2025
Harbour Investments, Inc
96.04K
0.21%
-67.00
-0.07%
Jun 30, 2025
Susquehanna International Group, LLP
80.67K
0.18%
+80.67K
--
Jun 30, 2025
Stifel, Nicolaus & Company, Incorporated
79.60K
0.17%
-500.00
-0.62%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: 18 hours ago
마지막 업데이트: 18 hours ago
이름
비율
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Core Equity 2 ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
날짜
유형
비율
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
